| Title |
HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
|
|---|---|
| Published in |
Breast Cancer, April 2018
|
| DOI | 10.1007/s12282-018-0861-9 |
| Pubmed ID | |
| Authors |
Hitomi Sakai, Junji Tsurutani, Tsutomu Iwasa, Yoshifumi Komoike, Kazuko Sakai, Kazuto Nishio, Kazuhiko Nakagawa |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 70 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 9 | 13% |
| Student > Postgraduate | 8 | 11% |
| Other | 7 | 10% |
| Student > Master | 6 | 9% |
| Student > Bachelor | 5 | 7% |
| Other | 13 | 19% |
| Unknown | 22 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 19% |
| Biochemistry, Genetics and Molecular Biology | 11 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 9% |
| Agricultural and Biological Sciences | 6 | 9% |
| Chemistry | 2 | 3% |
| Other | 7 | 10% |
| Unknown | 25 | 36% |